Effectiveness of IFN-γ for liver abscesses in chronic granulomatous disease

被引:15
作者
Conte, D
Fraquelli, M
Capsoni, F
Giacca, M
Zentilin, L
Bardella, MT
机构
[1] IRCCS, Osped Maggiore, Cattedra Gastroenterol, I-20122 Milan, Italy
[2] IRCCS, Osped Maggiore, Ist Med Interna, I-20122 Milan, Italy
[3] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy
关键词
D O I
10.1089/107999099313541
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In chronic granulomatous disease, interferon-gamma (IFN-gamma) significantly reduces the incidence and severity of recurrent infections, but its effectiveness administered ex novo during acute infection has been reported in only one case. In this report, we describe two adult brothers with chronic granulomatous disease treated successfully with IFN-gamma for acute liver abscesses. Two brothers with severe recurrent infections of unknown origin were hospitalized for septic fever, malnutrition, and ultrasonographic evidence of liver abscess. Autosomal recessive chronic granulomatous disease was diagnosed based on lack of superoxide anion production by phagocytes and absence of p47-phox protein. An antibiotic regimen specifically directed against Staphylococcus aureus was ineffective, whereas treatment with 50 mu g/m(2) IFN-gamma s.c. thrice weekly induced complete healing with scarring within 3 months, No septic recurrence was observed during a 4-year follow-up period. In chronic granulomatous disease, IFN-gamma is effective not only in preventing but also in healing life-threatening acute infections.
引用
收藏
页码:705 / 710
页数:6
相关论文
共 27 条
[1]   ANTITUMOR RESPONSE TO RECOMBINANT MURINE INTERFERON-GAMMA CORRELATES WITH ENHANCED IMMUNE FUNCTION OF ORGAN-ASSOCIATED, BUT NOT RECIRCULATING CYTOLYTIC T-LYMPHOCYTES AND MACROPHAGES [J].
BLACK, PL ;
PHILLIPS, H ;
TRIBBLE, HR ;
PENNINGTON, R ;
SCHNEIDER, M ;
TALMADGE, JE .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 37 (05) :299-306
[2]   Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils [J].
Capsoni, F ;
Minonzio, F ;
Ongari, AM ;
Carbonelli, V ;
Galli, A ;
Zanussi, C .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 45 (03) :269-275
[3]  
CHUSID MJ, 1978, PEDIATRICS, V62, P554
[4]  
DINAUER MC, 1992, ANNU REV MED, V43, P117, DOI 10.1146/annurev.me.43.020192.001001
[5]   A CONTROLLED TRIAL OF INTERFERON-GAMMA TO PREVENT INFECTION IN CHRONIC GRANULOMATOUS-DISEASE [J].
EZEKOWITZ, RAB .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (08) :509-516
[6]   RECOMBINANT INTERFERON GAMMA AUGMENTS PHAGOCYTE SUPEROXIDE PRODUCTION AND X-CHRONIC GRANULOMATOUS-DISEASE GENE-EXPRESSION IN X-LINKED VARIANT CHRONIC GRANULOMATOUS-DISEASE [J].
EZEKOWITZ, RAB ;
ORKIN, SH ;
NEWBURGER, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (04) :1009-1016
[7]   PARTIAL CORRECTION OF THE PHAGOCYTE DEFECT IN PATIENTS WITH X-LINKED CHRONIC GRANULOMATOUS-DISEASE BY SUBCUTANEOUS INTERFERON-GAMMA [J].
EZEKOWITZ, RAB ;
DINAUER, MC ;
JAFFE, HS ;
ORKIN, SH ;
NEWBURGER, PE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (03) :146-151
[8]  
EZEKOWITZ RAB, 1990, BLOOD, V76, P2443
[9]   PROGNOSIS OF CHRONIC GRANULOMATOUS-DISEASE [J].
FINN, A ;
HADZIC, N ;
MORGAN, G ;
STROBEL, S ;
LEVINSKY, RJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (09) :942-945
[10]   CLINICAL-FEATURES AND CURRENT MANAGEMENT OF CHRONIC GRANULOMATOUS-DISEASE [J].
FORREST, CB ;
FOREHAND, JR ;
AXTELL, RA ;
ROBERTS, RL ;
JOHNSTON, RB .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1988, 2 (02) :253-266